PAVAN, MATTEO
 Distribuzione geografica
Continente #
EU - Europa 332
AS - Asia 195
NA - Nord America 101
SA - Sud America 2
AF - Africa 1
Totale 631
Nazione #
FR - Francia 221
CN - Cina 116
US - Stati Uniti d'America 93
IT - Italia 43
MY - Malesia 23
NL - Olanda 16
VN - Vietnam 12
KR - Corea 11
PL - Polonia 11
DE - Germania 10
HK - Hong Kong 10
JP - Giappone 9
UA - Ucraina 7
CA - Canada 6
IN - India 6
GB - Regno Unito 5
RU - Federazione Russa 5
RO - Romania 3
SG - Singapore 3
AE - Emirati Arabi Uniti 2
HU - Ungheria 2
IR - Iran 2
MX - Messico 2
PT - Portogallo 2
AR - Argentina 1
AT - Austria 1
BE - Belgio 1
BR - Brasile 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
ES - Italia 1
IQ - Iraq 1
LT - Lituania 1
SE - Svezia 1
Totale 631
Città #
Beijing 101
Paris 47
Kuala Lumpur 23
Council Bluffs 22
Warsaw 10
Chicago 8
Ho Chi Minh City 8
Nam-gu 8
Padova 8
Amsterdam 7
Dieppe 7
Milan 7
Ayase 6
Hanoi 4
Hyderabad 4
Rome 4
San Francisco 4
Ashburn 3
Buffalo 3
East Brunswick 3
London 3
New York 3
Perugia 3
Toronto 3
Turin 3
Birmingham 2
Boardman 2
Casandrino 2
College Station 2
Denver 2
Florence 2
Henderson 2
Isfahan 2
Jamaica Plain 2
Marseille 2
Montreal 2
Mumbai 2
Negrar 2
Porto 2
Sanford 2
Szeged 2
Asiago 1
Azcapotzalco 1
Basel 1
Berlin 1
Bibbona 1
Bologna 1
Boston 1
Buenos Aires 1
Cambridge 1
Central 1
Chapel Hill 1
Ciudad Lopez Mateos 1
Cortlandt Manor 1
Crugers 1
Darmstadt 1
Denton 1
Des Moines 1
Dundee 1
East Setauket 1
Elk Grove Village 1
Erbil 1
Herndon 1
Incheon 1
Lincoln 1
Livorno 1
Los Angeles 1
Madrid 1
Merced 1
Newark 1
Oran 1
Overpelt 1
Prague 1
Rio de Janeiro 1
Rotonda 1
Rovigo 1
Ryugasaki 1
San Jose 1
Sassari 1
Seattle 1
Sesto Fiorentino 1
Shanghai 1
Shinge 1
Sibiu 1
Singapore 1
Sunnyvale 1
Tokyo 1
Treviso 1
Verdun 1
Verona 1
Vilnius 1
Wroclaw 1
Totale 385
Nome #
Tackling the COVID-19 pandemic through the combination of established and novel Computer-Aided Drug Discovery workflows, file 82e0ce9e-0b38-4c88-a517-79dfcbfa4892 209
IDENTIFICATION OF NEW SARS-COV-2 MAIN PROTEASE INHIBITORS BY AN INTEGRATED IN-SILICO AND IN-VITRO STRATEGY, file 66b45d9e-f853-4bd3-a309-7d5c9b3edde1 187
Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332, file e14fb270-0e41-3de1-e053-1705fe0ac030 46
A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1 delta, file e14fb26f-cd13-3de1-e053-1705fe0ac030 19
Thermal Titration Molecular Dynamics (TTMD): Not Your Usual Post-Docking Refinement, file e1a836c9-eeee-42ac-9713-7d5d1c42cb12 19
A new inactive conformation of SARS-CoV-2 main protease, file e14fb270-596b-3de1-e053-1705fe0ac030 18
Sodium or Not Sodium: Should Its Presence Affect the Accuracy of Pose Prediction in Docking {GPCR} Antagonists?, file e67cdfa6-9835-49fb-8e4f-3cbf908c7685 17
Implementing a Scoring Function Based on Interaction Fingerprint for Autogrow4: Protein Kinase CK1δ as a Case Study, file 54c72a68-d5fb-4b01-965e-a87ebc904b42 16
The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective?, file 239522a0-ae5b-45a8-a848-694420573128 15
Lessons Learnt from COVID-19: Computational Strategies for Facing Present and Future Pandemics, file ee07aa87-f655-4fc5-a8eb-9df9975e9df4 15
Discovery of the 3-Amino-1,2,4-triazine-Based Library as Selective PDK1 Inhibitors with Therapeutic Potential in Highly Aggressive Pancreatic Ductal Adenocarcinoma, file 1d68c172-23d1-43f6-8957-6110c2cfb328 14
Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir, file e14fb26e-8f2e-3de1-e053-1705fe0ac030 13
“Dual Anta-Inhibitors” of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies, file e84a3a8a-faa8-4d4b-8613-9b2a7353ae43 12
Ribose and Non-Ribose A2A Adenosine Receptor Agonists: Do They Share the Same Receptor Recognition Mechanism?, file cf077b85-4e8c-49fa-93fb-055862792ce3 10
From the Wuhan-Hu-1 strain to the XD and XE variants: is targeting the SARS-CoV-2 spike protein still a pharmaceutically relevant option against COVID-19?, file 67e2cbb5-086a-42fb-b858-a5125d663000 8
Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?, file af3382ce-18d3-47ef-95b6-1dc006891e6b 7
Re-Exploring the Ability of Common Docking Programs to Correctly Reproduce the Binding Modes of Non-Covalent Inhibitors of SARS-CoV-2 Protease Mpro, file c88d1918-55ca-4f6e-a076-bdbdb5a6c287 6
Totale 631
Categoria #
all - tutte 2.221
article - articoli 1.658
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.879


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023101 3 3 0 11 4 4 24 14 6 22 7 3
2023/2024530 4 8 12 6 43 205 77 82 70 22 1 0
Totale 631